Please assess the completion status of the following clinical trial:

Trial Title: Erythropoietin and Pediatric Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 6 weeks to 18 years~* Requiring open heart surgery for congenital heart defect -Parents able to speak English and document informed consent -~Exclusion Criteria:~* Received erythropoietin within past 30 days~* Previous adverse reaction to erythropoietin or to albumin~* History of neurological disorder -Laboratory evidence of kidney or liver dysfunction -

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 3 (Type: PLACEBO_COMPARATOR): acyanotic placebo
- 4 (Type: EXPERIMENTAL): acyanotic erythropoietin

Based on this trial design, predict the completion outcome and termination type (if applicable).